[go: up one dir, main page]

JPH08310937A - Preparation for external use - Google Patents

Preparation for external use

Info

Publication number
JPH08310937A
JPH08310937A JP13871895A JP13871895A JPH08310937A JP H08310937 A JPH08310937 A JP H08310937A JP 13871895 A JP13871895 A JP 13871895A JP 13871895 A JP13871895 A JP 13871895A JP H08310937 A JPH08310937 A JP H08310937A
Authority
JP
Japan
Prior art keywords
skin
neoagarobiose
hair
preparation
agar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP13871895A
Other languages
Japanese (ja)
Other versions
JP3505003B2 (en
Inventor
Masami Iida
正美 飯田
Mikimasa Takisada
幹正 滝貞
Masami Senoo
正巳 妹尾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kose Corp
Original Assignee
Kose Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kose Corp filed Critical Kose Corp
Priority to JP13871895A priority Critical patent/JP3505003B2/en
Publication of JPH08310937A publication Critical patent/JPH08310937A/en
Application granted granted Critical
Publication of JP3505003B2 publication Critical patent/JP3505003B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE: To obtain a preparation for external use excellent in beautifying and whitening effects on the skin and humectant effects on the skin and hair. CONSTITUTION: This preparation for external use contains 0.0001-30wt.%, preferably 0.1-5wt.% neoagarobiose which is one of heterobioses. The neoagarobiose has high suppressing actions on melanogenesis and is excellent humectant actions. The neoagarobiose is further suitably blended with ingredients usually used in cosmetics, quasi-drugs or medicines and a well-known medicine, as necessary, can be added thereto to prepare the neoagarobiose into a skin-care cosmetic, a makeup cosmetic, a detergent, a cosmetic for hair and a dermal preparation for external use. The neoagarobiose is obtained by culturing Alteromonas sp. E-1 which is one of microorganisms capable of producing an agar hydrolase, providing the agar hydrolase, then hydrolyzing agar or agarose therewith and cooling and freeze-drying the resultant hydrolyzate.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、ネオアガロビオースを
含有してなる外用剤に関し、さらに詳しくは、ネオアガ
ロビオースを含有することにより、皮膚に対する優れた
美白効果、皮膚および毛髪に対する優れた保湿効果を有
する外用剤に関する。
FIELD OF THE INVENTION The present invention relates to an external preparation containing neo-agarobiose. More specifically, by containing neo-agarobiose, it has an excellent whitening effect on the skin and an excellent effect on the skin and hair. And an external preparation having a moisturizing effect.

【0002】[0002]

【従来の技術】従来、外用剤において、皮膚の色黒、く
すみ、シミ、ソバカスの防止などの美容効果を得るため
のものとして、アスコルビン酸またはその誘導体、グル
タチオン、コロイドイオウ、プラセンタエキス、当帰エ
キス、桑白皮エキス、アロエエキス等を有効成分として
配合した美白化粧料等が知られている。また、乾燥等に
よる肌荒れや髪のパサツキなどを改善するために、保湿
剤としてグリセリン、尿素、アミノ酸またはその誘導
体、ヒアルロン酸等を配合した皮膚化粧料、毛髪化粧
料、皮膚外用剤等が知られている。
2. Description of the Related Art Conventionally, as an external preparation for obtaining cosmetic effects such as preventing skin darkening, dullness, spots, freckles, etc., ascorbic acid or its derivative, glutathione, colloidal sulfur, placenta extract, and so on. Whitening cosmetics and the like containing an extract, mulberry skin extract, aloe extract and the like as active ingredients are known. Further, in order to improve skin roughness due to dryness, dryness of hair, etc., skin cosmetics, hair cosmetics, external skin preparations, etc. containing glycerin, urea, amino acids or their derivatives, hyaluronic acid, etc. as moisturizers are known. ing.

【0003】[0003]

【発明が解決しようとする課題】しかしながら、美白化
粧料等において、アスコルビン酸はそれ自体が酸化され
やすいため経時的に一定の効果の発現が期待しにくく、
これを配合した化粧料等も変色しやすいという欠点があ
った。また、アスコルビン酸誘導体、プラセンタエキ
ス、当帰エキス、桑白皮エキス、アロエエキスは、これ
ら単独では効果が十分に高いとは言えず、さらに、グル
タチオンやコロイドイオウは配合後に特有の異臭を生じ
ることがあり、剤形によっては沈殿が生じる場合もある
という欠点を有していた。一方、皮膚の乾燥を防止して
肌荒れを改善したり、毛髪の乾燥を防止して髪のパサツ
キを改善するなどの保湿効果を有する外用剤において
も、グリセリン、尿素、アミノ酸またはその誘導体、ヒ
アルロン酸など従来の保湿剤を単独で使用した場合、十
分に高い効果を得るために配合量を多くすると製品の使
用感を損なう場合があった。そうした中にあり、より安
定性が良く、また皮膚に対する優れた美白効果、皮膚お
よび毛髪に対する優れた保湿効果を有する外用剤の開発
が望まれていた。
However, in whitening cosmetics and the like, ascorbic acid itself is easily oxidized, so that it is difficult to expect a certain effect to be exhibited over time.
The cosmetics and the like containing this also have a drawback that they are easily discolored. In addition, ascorbic acid derivative, placenta extract, toki extract, mulberry bark extract, aloe extract are not said to be sufficiently effective alone, and glutathione and colloidal sulfur produce a peculiar offensive odor after blending. However, there is a drawback that precipitation may occur depending on the dosage form. On the other hand, glycerin, urea, amino acids or their derivatives, hyaluronic acid can also be used as an external preparation having a moisturizing effect such as preventing dryness of skin to improve rough skin, and preventing dryness of hair to improve dryness of hair. When a conventional moisturizer is used alone, increasing the blending amount to obtain a sufficiently high effect may impair the usability of the product. Under these circumstances, it has been desired to develop an external preparation which is more stable and has an excellent whitening effect on the skin and an excellent moisturizing effect on the skin and hair.

【0004】[0004]

【課題を解決するための手段】かかる実情に鑑み、本発
明者らは糖類のもつ美白作用、保湿作用等につき鋭意研
究した結果、ネオアガロビオースが高いメラニン産生抑
制作用および優れた保湿作用を併せもち、これを配合し
た外用剤が皮膚の美白効果、皮膚および毛髪の保湿効果
において優れた性質を示すことを見いだし、本発明を完
成した。
In view of the above circumstances, the present inventors have diligently studied the whitening effect, the moisturizing effect and the like of saccharides, and as a result, have found that neo-agarobiose has a high melanin production inhibitory effect and an excellent moisturizing effect. In addition, the inventors have found that an external preparation containing the same exhibits excellent properties in skin whitening effect and skin and hair moisturizing effect, and completed the present invention.

【0005】すなわち、本発明はネオアガロビオースを
含有することを特徴とする外用剤である。
That is, the present invention is an external preparation characterized by containing neo-agarobiose.

【0006】本発明の外用剤に用いるネオアガロビオー
スは、ヘテロ二糖の1種であり、その調製方法は特に限
定はないが、例えば次に示すように、微生物由来の特定
の寒天分解酵素を用いて寒天またはアガロースを分解
し、調製する方法が挙げられる。
Neoagarobiose used in the external preparation of the present invention is one kind of heterodisaccharide, and its preparation method is not particularly limited. For example, as shown below, a specific agar-degrading enzyme derived from a microorganism is used. A method of decomposing agar or agarose with the use of and preparing.

【0007】まず、寒天分解酵素生産菌の1種であるア
ルテロモナス・エスピーE−1を常法に従って培養し、
培養液中より寒天分解酵素を得る。次に、10mMトリ
ス−塩酸緩衝溶液(pH7.5)に0.5%濃度になる
ように寒天またはアガロースを加え、これに上記寒天分
解酵素50mU/ml以上の濃度になるように添加し
て、40℃にて4時間以上作用させる。この溶液を沸騰
水中で5分間放置することにより反応を停止させ、4℃
に冷却する。ここで、特に寒天を基質とした場合には不
溶物の沈殿等が存在するため遠心分離により残渣を除去
する。得られた上澄液にネオアガロビオースが含まれる
ので、これを凍結乾燥することによりネオアガロビオー
スを得ることができる。
First, Alteromonas sp. E-1 which is one of the agar-degrading enzyme-producing bacteria is cultured according to a conventional method,
Agar-degrading enzyme is obtained from the culture solution. Next, agar or agarose was added to 10 mM Tris-hydrochloric acid buffer solution (pH 7.5) so as to have a concentration of 0.5%, and the agar-degrading enzyme was added thereto at a concentration of 50 mU / ml or more, It is allowed to act at 40 ° C for 4 hours or more. The reaction is stopped by leaving this solution in boiling water for 5 minutes to stop the reaction at 4 ° C.
Cool to. Here, especially when agar is used as the substrate, insoluble matter precipitates and the like, so the residue is removed by centrifugation. Since the obtained supernatant contains neo-agarobiose, it can be lyophilized to obtain neo-agarobiose.

【0008】本発明の外用剤において、ネオアガロビオ
ースの含有量は0.0001〜30重量%(以下、特に
記載のあるもの以外は重量%を単に%で示す)であるこ
とが好ましく、特に0.01〜5%の範囲がより好まし
い。
In the external preparation of the present invention, the content of neoagarobiose is preferably 0.0001 to 30% by weight (hereinafter,% by weight is simply represented by% unless otherwise specified), and particularly preferably The range of 0.01 to 5% is more preferable.

【0009】本発明の外用剤は、上記ネオアガロビオー
スの他、通常化粧品、医薬部外品、医薬品に用いられる
精製水、pH調製剤、低級アルコール、多価アルコー
ル、油剤、粉体、界面活性剤、水溶性高分子等を必要に
応じて適宜配合することにより調製され、また目的に応
じて本発明の効果を損なわない量的、質的範囲で、乳化
助剤、防腐剤、香料、緩衝液、色素等を配合することが
できる。
The external preparations of the present invention include, in addition to the above neoagarobiose, purified water, pH adjusting agents, lower alcohols, polyhydric alcohols, oils, powders, and interfaces commonly used for cosmetics, quasi drugs, and pharmaceuticals. Prepared by appropriately blending an activator, a water-soluble polymer and the like, if necessary, and in a quantitative and qualitative range that does not impair the effects of the present invention depending on the purpose, an emulsification aid, a preservative, a fragrance, A buffer solution, a dye and the like can be added.

【0010】また、本発明の外用剤は、必要によりさら
に公知の薬剤を添加しても良い。この薬剤としては、例
えば、アスコルビン酸またはその誘導体、プラセンタエ
キス、当帰エキス、桑白皮エキス、アロエエキス等の美
白効果を有する薬剤;グリセリン、尿素、アミノ酸また
はその誘導体、ヒアルロン酸等の保湿効果を有する薬
剤;グリチルレチン酸またはその誘導体、インドメタシ
ン等の抗炎症剤;ベンゾフェノン、パラアミノ安息香
酸、桂皮酸またはこれら各々の誘導体等の紫外線吸収
剤;ビタミンE、ローズマリーエキス、茶エキス等の酸
化防止剤等が挙げられる。これら薬剤は単独で用いて
も、2種以上を組み合わせて用いても良い。
If necessary, known agents may be added to the external preparation of the present invention. Examples of the drug include a drug having a whitening effect such as ascorbic acid or a derivative thereof, a placenta extract, a toki extract, a mulberry extract, an aloe extract; a moisturizing effect of glycerin, urea, an amino acid or a derivative thereof, hyaluronic acid and the like. Anti-inflammatory agents such as glycyrrhetinic acid or its derivatives and indomethacin; UV absorbers such as benzophenone, para-aminobenzoic acid, cinnamic acid or their respective derivatives; Antioxidants such as vitamin E, rosemary extract and tea extract Etc. These agents may be used alone or in combination of two or more kinds.

【0011】本発明の外用剤の剤形は特に限定されず、
化粧水、乳液、クリーム、パック、クレンジング料、マ
ッサージ料、美容液等のスキンケア化粧料;ファンデー
ション、口紅、頬紅等のメークアップ化粧料;洗顔料、
シャンプー、ボディソープ等の洗浄料;リンス、ヘアパ
ック等の毛髪用化粧料;軟膏剤、分散液等の皮膚外用剤
等、種々の剤形とすることができる。
The dosage form of the external preparation of the present invention is not particularly limited,
Skin care cosmetics such as lotions, emulsions, creams, packs, cleansing agents, massage agents, beauty essences; makeup cosmetics such as foundations, lipsticks and blushers; facial cleanser,
Various dosage forms can be used, such as detergents for shampoos, body soaps, cosmetics for hair such as rinses and hair packs, external preparations for skin such as ointments and dispersions.

【0012】[0012]

【実施例】以下に試験例および実施例を挙げて本発明を
さらに詳細に説明するが、これらは本発明を何ら限定す
るものではない。
EXAMPLES The present invention will be described in more detail below with reference to test examples and examples, but these do not limit the present invention in any way.

【0013】試験例1 メラニン産生抑制試験 2枚の6穴シャーレに培地を適量取り、B16メラノー
マを播種し、37℃、二酸化炭素濃度5%中にて静置す
る。翌日、ネオアガロビオース(注1)を最終濃度が各
々0(対照)、1、10、100μg/mlとなるよう
に検体調製液を添加混和する。培養5日目に培地を交換
し、再度検体調製液を添加する。翌日、培地を除き、1
枚のシャーレについて、細胞をPBS(リン酸緩衝液)
にて洗浄後、回収し、B16メラノーマの白色化度を評
価した。 (注1:本明細書に例示の方法にて調製したもの)
Test Example 1 Melanin Production Inhibition Test An appropriate amount of the medium was placed in two 6-well petri dishes, and B16 melanoma was inoculated and allowed to stand at 37 ° C. in a carbon dioxide concentration of 5%. The next day, the sample preparation solution is added and mixed so that the final concentrations of neoagarobiose (Note 1) are 0 (control), 1, 10, and 100 μg / ml, respectively. On the 5th day of culture, the medium is exchanged and the sample preparation solution is added again. The next day, remove the medium and
Cells (PBS (phosphate buffer solution))
After washing in, it was collected and the whitening degree of B16 melanoma was evaluated. (Note 1: Prepared by the method exemplified in this specification)

【0014】白色化度の評価基準は以下に示すとおりで
ある。 ++ :プラセンタエキス100μg/ml添加時よ
り白くなった。 + :プラセンタエキス100μg/ml添加時と
同程度に白くなった。 ± :プラセンタエキス100μg/ml添加時よ
り白くならないが、対照より白くなった。 − :対照と同程度。
The evaluation criteria of whitening degree are as follows. ++: It became whiter than when 100 μg / ml of placenta extract was added. +: Whitened to the same extent as when 100 μg / ml of placenta extract was added. ±: Not whiter than when 100 μg / ml of placenta extract was added, but whiter than the control. -: Similar to the control.

【0015】残りの1枚のシャーレについて、細胞をホ
ルマリン固定後、1%クリスタルバイオレット溶液を添
加し、染色する。各検体濃度に対する生存細胞数(A)
および対照の細胞数(B)を測定し、式(1)により細
胞生存率を算出した。以上の結果を表1に示す。
For the remaining one dish, cells are fixed with formalin, and a 1% crystal violet solution is added for staining. Number of viable cells for each sample concentration (A)
And the cell number (B) of the control was measured, and the cell viability was calculated by the formula (1). Table 1 shows the above results.

【0016】[0016]

【式1】 (Equation 1)

【0017】[0017]

【表1】 [Table 1]

【0018】表1の結果より明らかな如く、本発明に用
いるネオアガロビオースは、B16メラノーマに対し細
胞毒性が低く、かつ高いメラニン産生抑制能を有するこ
とが認められた。このことは、皮膚においてネオアガロ
ビオースが高い美白効果を有することを示す。
As is clear from the results shown in Table 1, it was confirmed that neo-agarobiose used in the present invention has low cytotoxicity to B16 melanoma and has a high melanin production suppressing ability. This indicates that neo agarobiose has a high whitening effect on the skin.

【0019】試験例2 保湿性試験 表2に示す4種の保湿剤とネオアガロビオース(注1と
同じもの)について、各々試料0.1gを精秤し、40
℃、75%の恒温恒湿槽に3日間静置する。このときの
重量を測定し、このときの重量増加率をもって保湿性を
評価した。
Test Example 2 Moisture Retention Test For each of the four moisturizers and neo agarobiose (the same as in Note 1) shown in Table 2, 0.1 g of each sample was precisely weighed and 40
Let stand for 3 days in a thermo-hygrostat at 75 ° C. The weight at this time was measured, and the moisturizing property was evaluated by the weight increase rate at this time.

【0020】[0020]

【表2】 [Table 2]

【0021】表2の結果より明らかな如く、本発明に用
いるネオアガロビオースは他の保湿剤に比べて吸湿性が
高く、保湿効果に優れていた。
As is clear from the results shown in Table 2, neoagarobiose used in the present invention has a higher hygroscopicity and an excellent moisturizing effect than other moisturizers.

【0022】実施例1および比較例1 乳液 下に示す組成および製法で乳液を調製し、使用試験を行
って、その美白効果および保湿作用による肌荒れ改善効
果を下記評価方法および評価基準により評価した。結果
を表3に示す。
Example 1 and Comparative Example 1 Emulsion An emulsion was prepared according to the composition and the production method shown below, and a usage test was conducted to evaluate the whitening effect and the rough skin improving effect due to the moisturizing effect according to the following evaluation methods and evaluation criteria. The results are shown in Table 3.

【0023】<実施例1> (組成) (成 分) (重量%) (1)スクワラン 5 (2)ワセリン 2 (3)ミツロウ 0.5 (4)セスキオレイン酸ソルビタン 0.8 (5)ポリオキシエチレンオレイルエーテル(20E.O.) 1.2 (6)1,3−ブチレングリコール 5 (7)ネオアガロビオース(注1と同じもの) 2 (8)エチルアルコール 5 (9)防腐剤 適 量 (10)香料 適 量 (11)水酸化ナトリウム 0.1 (12)カルボキシビニルポリマー(1%水溶液) 20 (13)精製水 残 量<Example 1> (Composition) (Component) (% by weight) (1) Squalane 5 (2) Vaseline 2 (3) Beeswax 0.5 (4) Sorbitan sesquioleate 0.8 (5) Poly Oxyethylene oleyl ether (20 EO) 1.2 (6) 1,3-butylene glycol 5 (7) Neoagarobiose (same as Note 1) 2 (8) Ethyl alcohol 5 (9) Preservative Suitable Quantity (10) Perfume Suitable quantity (11) Sodium hydroxide 0.1 (12) Carboxyvinyl polymer (1% aqueous solution) 20 (13) Purified water Residual quantity

【0024】(製法) A.成分(6)〜(8)、(12)および(13)を加
熱混合し、70℃に保つ。 B.成分(1)〜(5)および(9)を加熱混合し、7
0℃に保つ。 C.BにAおよび成分(10)を加えて均一に混和した
後、(11)を加えて均一に乳化し、30℃まで冷却し
て乳液を得る。
(Production Method) A. Ingredients (6)-(8), (12) and (13) are heat mixed and maintained at 70 ° C. B. The components (1) to (5) and (9) are heated and mixed, and
Keep at 0 ° C. C. After A and component (10) are added to B and mixed uniformly, (11) is added to uniformly emulsify and cool to 30 ° C. to obtain an emulsion.

【0025】<比較例1>組成は実施例1の組成からネ
オアガロビオースを除き、代わりに同量の精製水を加え
たものである。製法は実施例1の製法に準じたものであ
る。
<Comparative Example 1> The composition is the composition of Example 1 except that neoagarobiose is removed, and the same amount of purified water is added instead. The manufacturing method is based on the manufacturing method of Example 1.

【0026】(評価方法)30〜50才の20名の女性
をパネルとし、実施例1、比較例1の乳液2品につい
て、2週間にわたって毎日、朝と夜の2回、洗顔後に適
量を顔面に塗布してもらった。塗布による美白効果およ
び肌荒れ改善効果を下の評価基準によって評価した。
(Evaluation method) Twenty women aged 30 to 50 years were used as a panel, and two emulsions of Example 1 and Comparative Example 1 were used for 2 weeks, twice daily in the morning and night, and after washing the face, an appropriate amount was applied to the face. I got it applied to. The whitening effect and the rough skin improving effect by application were evaluated according to the following evaluation criteria.

【0027】(評価基準) [美白効果] 有 効 : シミ・ソバカス・くすみがほとんど目立
たなくなった。 やや有効 : シミ・ソバカス・くすみがあまり目立た
なくなった。 無 効 : 変わらない [肌荒れ改善効果] 有 効 : 肌のかさつきや荒れが改善された。 やや有効 : 肌のかさつきや荒れがやや改善された。 無 効 : 変わらない
(Evaluation Criteria) [Whitening Effect] Effective: Spots, freckles, and dullness were almost inconspicuous. Slightly effective: Spots, freckles, and dullness are less noticeable. No effect: No change [Effect of improving rough skin] Effective: Improves the roughness and roughness of the skin. Slightly effective: The bulkiness and roughness of the skin were slightly improved. Ineffective: Does not change

【0028】[0028]

【表3】 [Table 3]

【0029】表3の結果より明らかなように、実施例1
の乳液は比較例1のものに比べ、シミ、ソバカス、くす
みの解消や肌のかさつき、荒れの改善において良好な結
果が得られ、美白効果および保湿による肌荒れ改善効果
に優れた効果を示した。
As is clear from the results of Table 3, Example 1
Compared with the emulsion of Comparative Example 1, good results were obtained in the removal of spots, freckles, dullness and improvement of skin roughness and roughness, and the emulsion of Example 1 showed an excellent effect of whitening effect and rough skin improving effect by moisturizing.

【0030】実施例2および比較例2 クリーム 下に示す組成および製法でクリームを調製し、使用試験
によりその美白効果を評価した。評価方法および評価基
準は、実施例1および比較例1の方法と同じである。結
果を表4に示す。
Example 2 and Comparative Example 2 Cream A cream was prepared by the composition and production method shown below, and its whitening effect was evaluated by a usage test. The evaluation method and evaluation criteria are the same as those in Example 1 and Comparative Example 1. The results are shown in Table 4.

【0031】<実施例2> (組成) (成 分) (重量%) (1)ミツロウ 6 (2)セタノール 5 (3)還元ラノリン 8 (4)スクワラン 1.5 (5)グリセリンモノステアレート 0.5 (6)親油性モノステアリン酸グリセリン 13 (7)ポリオキシエチレンソルビタンモノ ラウリン酸エステル(20E.O.) 2 (8)ネオアガロビオース(注1と同じもの) 2 (9)防腐剤 0.1 (10)香料 適 量 (11)1,3−ブチレングリコール 5 (12)精製水 残 量<Example 2> (Composition) (Component) (% by weight) (1) Beeswax 6 (2) Cetanol 5 (3) Reduced lanolin 8 (4) Squalane 1.5 (5) Glycerin monostearate 0 .5 (6) Lipophilic glyceryl monostearate 13 (7) Polyoxyethylene sorbitan monolaurate (20 EO) 2 (8) Neo agarobiose (same as Note 1) 2 (9) Preservative 0.1 (10) Perfume proper amount (11) 1,3-butylene glycol 5 (12) Purified water balance

【0032】(製法) A.成分(1)〜(7)、(9)および(10)を加熱
混合し、70℃に保つ。 B.成分(8)、(11)および(12)を加熱混合
し、70℃に保つ。 C.BにAを加えて乳化し、30℃まで冷却して、クリ
ームを得る。
(Production Method) A. The components (1) to (7), (9) and (10) are mixed by heating and kept at 70 ° C. B. Ingredients (8), (11) and (12) are heat mixed and maintained at 70 ° C. C. Add A to B to emulsify and cool to 30 ° C. to obtain a cream.

【0033】<比較例2>組成は実施例2の組成からネ
オアガロビオースを除き、代わりに同量の精製水を加え
たものである。製法は実施例2の製法に準じたものであ
る。
<Comparative Example 2> The composition is the same as that of Example 2 except that neoagarobiose is removed, and the same amount of purified water is added instead. The manufacturing method is based on the manufacturing method of Example 2.

【0034】[0034]

【表4】 [Table 4]

【0035】表4の結果より明らかなように、実施例2
のクリームは比較例2のものに比べ、シミ、ソバカス、
くすみの解消において良好な結果が得られ、優れた美白
効果を示した。
As is clear from the results shown in Table 4, Example 2
Compared to the cream of Comparative Example 2, the cream of spots, freckles,
Good results were obtained in eliminating dullness, and an excellent whitening effect was exhibited.

【0036】実施例3および比較例3 化粧水 下に示す組成および製法で化粧水を調製し、その保湿作
用による肌荒れ改善効果を、使用試験により評価した。
評価方法および評価基準は、実施例1および比較例1の
方法と同じである。結果を表5に示す。
Example 3 and Comparative Example 3 Lotion A lotion was prepared by the composition and production method shown below, and the effect of moisturizing skin roughening was evaluated by a use test.
The evaluation method and evaluation criteria are the same as those in Example 1 and Comparative Example 1. The results are shown in Table 5.

【0037】<実施例3> (組成) (成 分) (重量%) (1)グリセリン 2.5 (2)1,3−ブチレングリコール 3.5 (3)オレイルアルコール 0.1 (4)ポリオキシエチレンソルビタン モノラウリン酸エステル(20E.O.) 1.5 (5)ポリオキシエチレンラウリルエーテル(20E.O.) 0.5 (6)エチルアルコール 13 (7)ソルビトール 1 (8)ネオアガロビオース(注1と同じもの) 0.01 (9)ビタミンE 0.1 (10)オキシベンゾン 0.2 (11)防腐剤 適 量 (12)香料 適 量 (13)精製水 残 量<Example 3> (Composition) (Component) (wt%) (1) Glycerin 2.5 (2) 1,3-butylene glycol 3.5 (3) Oleyl alcohol 0.1 (4) Poly Oxyethylene sorbitan monolaurate (20EO) 1.5 (5) Polyoxyethylene lauryl ether (20EO) 0.5 (6) Ethyl alcohol 13 (7) Sorbitol 1 (8) Neoagarobiose (Same as Note 1) 0.01 (9) Vitamin E 0.1 (10) Oxybenzone 0.2 (11) Preservative Suitable amount (12) Perfume Suitable amount (13) Purified water Residual amount

【0038】(製法) A.成分(3)〜(6)および(9)〜(12)を混合
溶解する。 B.成分(1)、(2)、(7)、(8)および(1
3)を混合溶解する。 C.AとBを混合して均一にし、化粧水を得る。
(Production Method) A. Components (3) to (6) and (9) to (12) are mixed and dissolved. B. Components (1), (2), (7), (8) and (1
Mix and dissolve 3). C. Mix A and B to make uniform and obtain lotion.

【0039】<比較例3>組成は実施例3の組成からネ
オアガロビオースを除き、代わりに同量の精製水を加え
たものである。製法は実施例3の製法に準じたものであ
る。
<Comparative Example 3> The composition is the same as that of Example 3, except that neoagarobiose was removed, and the same amount of purified water was added instead. The manufacturing method is based on the manufacturing method of Example 3.

【0040】[0040]

【表5】 [Table 5]

【0041】表5の結果より明らかなように、実施例3
の化粧水は比較例3のものに比べ、肌のかさつき、荒れ
の改善において良好な結果が得られ、保湿による肌荒れ
改善効果に優れた効果を示した。
As is clear from the results in Table 5, Example 3
As compared with Comparative Example 3, the lotion of No. 3 gave good results in improving the bulkiness and roughness of the skin, and showed an excellent effect of improving skin roughness by moisturizing.

【0042】実施例4および比較例4 ヘアシャンプ
ー 下に示す組成および製法でヘアシャンプーを調製し、使
用試験を行って、その毛髪保湿効果を下記評価方法およ
び評価基準により評価した。結果を表6に示す。
Example 4 and Comparative Example 4 Hair Shampoo A hair shampoo was prepared according to the composition and production method shown below, and a usage test was conducted to evaluate the moisturizing effect of hair according to the following evaluation methods and evaluation criteria. The results are shown in Table 6.

【0043】<実施例4> (組成) (成 分) (重量%) (1)ラウリル硫酸トリエタノールアミン 16 (2)ラウリン酸ジエタノールアミド 4 (3)プロピレングリコール 2 (4)防腐剤 適 量 (5)香料 適 量 (6)ネオアガロビオース(注1と同じもの) 1.5 (7)精製水 残 量<Example 4> (Composition) (Component) (% by weight) (1) Lauryl sulfate triethanolamine 16 (2) Lauric acid diethanolamide 4 (3) Propylene glycol 2 (4) Preservative proper amount ( 5) Appropriate amount of fragrance (6) Neo agarobiose (same as Note 1) 1.5 (7) Residual amount of purified water

【0044】(製法) A.成分(1)〜(5)を混合溶解する。 B.成分(6)および(7)を混合溶解する。 C.AにBを加えて均一に混合し、ヘアシャンプーを得
る。
(Production Method) A. Components (1) to (5) are mixed and dissolved. B. Components (6) and (7) are mixed and dissolved. C. Add B to A and mix evenly to obtain a hair shampoo.

【0045】<比較例4>組成は実施例4の組成からネ
オアガロビオースを除き、代わりに同量の精製水を加え
たものである。製法は実施例4の製法に準じたものであ
る。
<Comparative Example 4> The composition is the composition of Example 4 except that neoagarobiose is removed, and the same amount of purified water is added instead. The manufacturing method is based on the manufacturing method of Example 4.

【0046】(評価方法)25〜45才の20名の女性
をパネルとし、実施例4、比較例4のヘアシャンプー2
品について、5日間にわたって毎日1回洗髪してもらっ
た。洗髪による毛髪保湿効果を下の評価基準によって評
価した。
(Evaluation method) Hair shampoo 2 of Example 4 and Comparative Example 4 with 20 women aged 25 to 45 as panels
The product was washed once a day for 5 days. The moisturizing effect of hair washing was evaluated according to the following evaluation criteria.

【0047】(評価基準) [毛髪保湿効果] 有 効 : 毛髪のしっとり感が増し、髪が滑らかに
なった。 やや有効 : 毛髪のしっとり感がやや増し、髪がやや
滑らかになった。 無 効 : 変わらない
(Evaluation Criteria) [Hair Moisturizing Effect] Effectiveness: The moist feeling of the hair was increased and the hair became smooth. Slightly effective: The moist feeling of the hair was slightly increased, and the hair became slightly smooth. Ineffective: Does not change

【0048】[0048]

【表6】 [Table 6]

【0049】表6の結果より明らかなように、実施例4
のヘアシャンプーは比較例4のものに比べ、髪のしっと
り感の付与において良好な結果が得られ、優れた毛髪保
湿効果を示した。
As is clear from the results of Table 6, Example 4
The hair shampoo of No. 3 gave better results in imparting a moisturizing feeling to the hair and showed an excellent moisturizing effect on hair, as compared with the hair shampoo of Comparative Example 4.

【0050】実施例5 パック 下に示す組成および製法でパックを調製した。 <実施例5> (組成) (成 分) (重量%) (1)ポリビニルアルコール 15 (2)カルボキシメチルセルロースナトリウム 5 (3)プロピレングリコール 3 (4)ネオアガロビオース(注1と同じもの) 5 (5)エチルアルコール 10 (6)オキシベンゾン 0.1 (7)防腐剤 適 量 (8)香料 適 量 (9)精製水 残 量Example 5 Pack A pack was prepared with the following composition and production method. <Example 5> (Composition) (Component) (% by weight) (1) Polyvinyl alcohol 15 (2) Sodium carboxymethyl cellulose 5 (3) Propylene glycol 3 (4) Neo agarobiose (the same as Note 1) 5 (5) Ethyl alcohol 10 (6) Oxybenzone 0.1 (7) Preservative proper amount (8) Perfume proper amount (9) Purified water balance

【0051】(製法) A.成分(1)〜(4)および(9)を混合し、攪拌し
ながら70℃にて加熱溶解する。 B.成分(5)〜(7)および(8)を混合溶解する。 C.AにBを加え、均一に混合した後冷却して、パック
を得る。
(Production Method) A. Components (1) to (4) and (9) are mixed and dissolved by heating at 70 ° C. with stirring. B. Components (5) to (7) and (8) are mixed and dissolved. C. B is added to A, mixed uniformly, and then cooled to obtain a pack.

【0052】以上のようにして得られた実施例5のパッ
クは、シミ、ソバカス、くすみの解消や肌のかさつき、
荒れの改善において良好な結果が得られた。
The pack of Example 5 obtained as described above was used to eliminate spots, freckles, dullness, and skin roughness.
Good results were obtained in improving roughness.

【0053】[0053]

【発明の効果】以上詳述した如く、本発明の外用剤は皮
膚の美白効果、皮膚および毛髪の保湿効果において優れ
た性質を示す。
As described above in detail, the external preparation of the present invention exhibits excellent properties in whitening the skin and moisturizing the skin and hair.

フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 7/075 A61K 7/075 31/70 ADA 31/70 ADA Continuation of front page (51) Int.Cl. 6 Identification code Office reference number FI Technical display area A61K 7/075 A61K 7/075 31/70 ADA 31/70 ADA

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】ネオアガロビオースを含有することを特徴
とする外用剤。
1. An external preparation characterized by containing neo-agarobiose.
【請求項2】ネオアガロビオースを美白剤として含有す
ることを特徴とする請求項1記載の外用剤。
2. The external preparation according to claim 1, which contains neo-agarobiose as a whitening agent.
【請求項3】ネオアガロビオースを保湿剤として含有す
ることを特徴とする請求項1記載の外用剤。
3. The external preparation according to claim 1, which contains neo-agarobiose as a moisturizing agent.
JP13871895A 1995-05-12 1995-05-12 External preparation Expired - Lifetime JP3505003B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13871895A JP3505003B2 (en) 1995-05-12 1995-05-12 External preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13871895A JP3505003B2 (en) 1995-05-12 1995-05-12 External preparation

Publications (2)

Publication Number Publication Date
JPH08310937A true JPH08310937A (en) 1996-11-26
JP3505003B2 JP3505003B2 (en) 2004-03-08

Family

ID=15228524

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13871895A Expired - Lifetime JP3505003B2 (en) 1995-05-12 1995-05-12 External preparation

Country Status (1)

Country Link
JP (1) JP3505003B2 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1313031C (en) * 1999-05-14 2007-05-02 宝生物工程株式会社 Agarobiose-contg. composition
JP2007269636A (en) * 2006-03-30 2007-10-18 Kose Corp Interleukin 6 production inhibitor
JP2009102279A (en) * 2007-10-25 2009-05-14 Kose Corp Anti-wrinkle agent and external preparation for skin to prevent formation of wrinkle
JP2012121910A (en) * 2012-03-05 2012-06-28 Kose Corp Interleukin 6 production inhibitor
CN109731001A (en) * 2019-02-13 2019-05-10 蓝脑科技(厦门)有限公司 The newly new application of fine jade oligosaccharides and the composition containing new fine jade oligosaccharides
CN110960439A (en) * 2019-12-31 2020-04-07 蓝脑科技(厦门)有限公司 Agar oligosaccharide-oligopeptide composition, preparation method and composition for repairing skin inflammation

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1313031C (en) * 1999-05-14 2007-05-02 宝生物工程株式会社 Agarobiose-contg. composition
JP2007269636A (en) * 2006-03-30 2007-10-18 Kose Corp Interleukin 6 production inhibitor
JP2009102279A (en) * 2007-10-25 2009-05-14 Kose Corp Anti-wrinkle agent and external preparation for skin to prevent formation of wrinkle
JP2012121910A (en) * 2012-03-05 2012-06-28 Kose Corp Interleukin 6 production inhibitor
CN109731001A (en) * 2019-02-13 2019-05-10 蓝脑科技(厦门)有限公司 The newly new application of fine jade oligosaccharides and the composition containing new fine jade oligosaccharides
CN110960439A (en) * 2019-12-31 2020-04-07 蓝脑科技(厦门)有限公司 Agar oligosaccharide-oligopeptide composition, preparation method and composition for repairing skin inflammation
CN110960439B (en) * 2019-12-31 2022-05-10 蓝脑科技(厦门)有限公司 Agar oligosaccharide-oligopeptide composition, preparation method and composition for repairing skin inflammation

Also Published As

Publication number Publication date
JP3505003B2 (en) 2004-03-08

Similar Documents

Publication Publication Date Title
EP1600143B1 (en) SKIN PREPARATION FOR EXTERNAL USE CHARACTERIZED BY CONTAINING SUGAR DERIVATIVE OF a,a-TREHALOSE
EP2116224B1 (en) Cosmetic composition
JP3513873B2 (en) External preparation for skin
WO2002060395A1 (en) Cosmetics
JP3513872B2 (en) External preparation for skin
JP3758794B2 (en) Collagen production promoter and anti-aging skin external preparation containing the same
JPH0859450A (en) External preparation for skin
JP2015040173A (en) External preparation for skin
JP3505003B2 (en) External preparation
JP2003137768A (en) Antiaging agent
JP3278138B2 (en) External preparation for skin
JPH1029927A (en) Antiaging agent
JP5226200B2 (en) Sulfated glycosaminoglycan production promoter and skin external preparation containing the same
JP3507635B2 (en) Composition suitable for external use
JP3083105B2 (en) Cosmetics
JP2004097999A (en) Emulsifier and cosmetic
JP4500906B2 (en) Cosmetic compounding agent and cosmetics containing the same
JP4621958B2 (en) Cosmetic compounding agent and cosmetics containing the same
JP2003252743A (en) Tyrosinase activity inhibitor, melanogenesis inhibitor and skin care preparation containing them
JP2000143485A (en) Composition for controlling aging of dermal cell
JP2001039816A (en) Inhibitor against formation of crosslink in collagen
JP3526806B2 (en) Cosmetics
JPH0529322B2 (en)
JP2005247732A (en) External preparation for skin
JP2001172160A (en) Skin preparation for external use

Legal Events

Date Code Title Description
A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20031212

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121219

Year of fee payment: 9

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131219

Year of fee payment: 10

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term